AstraZeneca
AZN
#63
Rank
S$338.24 B
Marketcap
S$218.10
Share price
-0.23%
Change (1 day)
20.35%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: S$338.24 Billion

As of July 2026 AstraZeneca has a market cap of S$338.24 Billion. This makes AstraZeneca the world's 63th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$338.24 B-8.48%
2025S$369.60 B33.55%
2024S$276.75 B0.18%
2023S$276.25 B-2.05%
2022S$282.04 B14.97%
2021S$245.32 B41.57%
2020S$173.28 B-1.79%
2019S$176.44 B36.78%
2018S$128.99 B10.7%
2017S$116.53 B16.75%
2016S$99.81 B-18.39%
2015S$122.29 B3.34%
2014S$118.34 B26.05%
2013S$93.88 B30.97%
2012S$71.68 B-8.55%
2011S$78.38 B-6.5%
2010S$83.83 B-12.32%
2009S$95.61 B12.58%
2008S$84.93 B-5.4%
2007S$89.77 B-28.63%
2006S$125.79 B-3.21%
2005S$129.95 B33.16%
2004S$97.59 B-29.87%
2003S$139.16 B32.99%
2002S$104.64 B-30.5%
2001S$150.56 B-4.48%
2000S$157.62 B27.68%
1999S$123.45 B75.42%
1998S$70.37 B22.17%
1997S$57.60 B55.19%
1996S$37.11 B

End of Day market cap according to different sources

On Jul 18th, 2026 the market cap of AstraZeneca was reported to be:

S$338.21 Billion
by Nasdaq info icon info icon
S$338.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$786.55 B 132.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$378.85 B 12.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$184.36 B-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$226.44 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.357 T 301.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$138.04 B-59.19%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$39.27 B-88.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$406.63 B 20.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$160.16 B-52.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$133.86 B-60.42%๐Ÿ‡ฌ๐Ÿ‡ง UK